Meta description: A new crossover trial evaluates transcutaneous electrical nerve stimulation for labor pain, signaling regulatory interest in device based relief during childbirth. The study is sponsored by Ricardo A Gutierrez Ramirez and is currently recruiting, with a trial page on ClinicalTrials.gov listed as NCT07401147 on 2026 02 11.
The trial tests the TENSCARE Perfect Mama plus TENS unit against a sham comparator in a crossover design to examine pain intensity, analgesic use, and safety signals during labor. This approach aims to generate comparative data across conditions in the same participant, which can improve the precision of observed effects while maintaining participant safety.
What changed in the field of labor pain management with TENS?
The use of a TENS device in labor spans patient comfort and non pharmacologic relief. This trial adds a crossover element to the evidence base by having participants experience both active TENS and a sham control across time. The trial page lists TENSCARE Perfect Mama plus as the active device and a sham comparator to isolate the effect of the electrical stimulation from placebo. The clinical significance of results will hinge on objective and subjective pain measures, labor duration, and safety observations during and after device use.
How is this trial designed and who participates?
The study is described as a crossover clinical trial focused on labor pain. In a crossover design each participant may receive both the active TENS intervention and the sham condition at different times, reducing inter subject variability. The recruitment status indicates ongoing enrollment. The sponsor is listed as Ricardo A Gutierrez Ramirez, MD, MSc, FACOG, underscoring clinical leadership. The trial site or sites are not specified in the available text, but the design is described as device based with a sham comparator to strengthen the validity of observed effects.
What device and comparator are used and what is the regulatory framing?
The device under study is the Transcutaneous Electrical Nerve Stimulation system known as TENSCARE Perfect Mama plus. The comparator is a sham device that mimics appearance and handling without delivering therapeutic electrical stimulation. This arrangement aligns with standard experimental controls and supports attempts to distinguish genuine analgesic effects from placebo. The regulatory framing follows standard device categories and supports regulatory expectations for medical devices used in pain management. The sponsor statements reflect medical leadership and regulatory compliance considerations rather than clinical claims.
What are the safety and performance expectations and how will results be measured?
Safety endpoints for a TENS based intervention in labor typically include skin tolerance at electrode sites, device reliability, and any adverse events related to use during labor. Performance measures would focus on pain reduction, analgesic consumption, patient satisfaction, and potential impact on labor progress. The trial description implies a structured comparison between active stimulation and sham to isolate treatment effects while ensuring participant safety. Results from this trial could inform future labeling or clinical guidelines when robust data are available.
What are the regulatory implications for medical devices in this context?
Regulatory implications center on the intended use, performance claims, and safety narrative associated with a TENS device in labor care. If the crossover trial yields clear evidence of pain relief with acceptable safety, manufacturers may pursue more explicit labeling for labor related indications and workflow integration with obstetric care. The MDR style requires clear statements of intended purpose, performance attributes, and safety considerations; sponsor or investigator statements should be labeled as such. The current information shows the trial is exploratory and not a product approval step, but findings could shape regulatory dialogue and future submissions.
What is the status and where to access official details?
According to the source text, recruitment is ongoing and information is accessible via ClinicalTrials.gov. The trial page for NCT07401147 lists the device as a TENS unit and indicates a sham comparator in a labor pain context. Researchers and sponsors should monitor enrollment and reporting milestones to inform regulatory and clinical audiences about any progress or results as they become available.
FAQ
- 1. What is the purpose of this trial The trial aims to evaluate the safety and effectiveness of a TENS device for labor pain relief in a crossover design.
- 2. Which device is used The TENSCARE Perfect Mama plus is the active device and a sham comparator is used for control.
- 3. What if results show a benefit Positive data would require further validation and could influence future labeling discussions under MDR considerations.
Conclusion
This question driven study represents an early evidence generation step for device based pain management in labor. While results are not yet available, the design highlights how regulatory minded trials can inform patient care without over claiming outcomes. Stakeholders should watch trial updates on the official ClinicalTrials.gov page and consider implications for labeling and clinical practice if findings prove robust and reproducible.
Disclaimer
The information in this article is intended for professionals and does not constitute legal advice. It reflects publicly available trial details and not a formal regulatory submission. For legal or regulatory strategies, practitioners should consult qualified counsel and refer to MDR requirements.
Announcement line
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07401147?term=medical+device